Shantha Biotechnics, the Chennai based bio-pharmaceuticals company is setting up
a new vaccine manufacturing complex near Hyderabad, Andhra Pradesh.
The
company plans to invest Rs.50 crore initially and later invest another Rs.50
crore. The complex will come up on 40 acre in the Genome Valley Biotech Park at
Muppireddypally village in Ranga Reddy district, and will have a capacity to
manufacture over 100 million doses of vaccines per year.
The
complex will address the capacity constraints of the company's existing
facilities to manufacture a range of enteric (relating to intestine) vaccines
and the new generation pneumococcal vaccines, which are under development.